Hair Care and Hair Products for Optimal Patient Outcomes
Registration Fees Per Webinar:
- ISHRS Physician Member, $50.00 USD
- ISHRS Physician Pending-Member, $75.00 USD
- Physician Non Member, $100.00 USD
The recorded program will be available for viewing on demand until Dec. 31, 2022.
This 2-hour webinar is being conducted to provide physicians knowledge on hair care products, vitamin and mineral supplements to help hair loss, dermatopathology of common hair problems and update on hair loss disorders after COVID-19. As a result of this activity, learners will be able to gain more knowledge to help treating the patients with hair loss disorders. The online live component will include presentations, panel discussion, and audience participation via verbal questions and discussion, typing chat Q&A and polling
Professional Practice Gap
To give a correct diagnosis of the hair loss disorders, hair pathology is necessary as an important fundamental. Scalp biopsy is necessary to evaluate scarring alopecia and other non-scarring alopecia. There are several evidences to support a role for vitamins and micronutrients in non-scarring alopecia.
In this webinar, the role of vitamins and minerals, such as vitamin B, vitamin C, vitamin D, vitamin E, iron, selenium, and zinc, in non-scarring alopecia will be summarized. Hair care products are also helpful to treat the hair shaft disorders and promote the healthy look of hair. Finally, in the COVID era, there are several reports of telogen effluvium after infection and it is thought to involve more rigorously patients with androgenetic alopecia. The updated data regarding this topic will be presented in the webinar.
Knowledge of hair pathology is essential for successful hair specialists, as it helps in the diagnosis of hair loss disorders. Specifically, physicians must understand the pathological findings of common hair disorders, for example, alopecia areata, lichen planopilaris, lupus erythematosus, and other scarring alopecia. Giving a correct diagnosis leads to successful treatment planning. Performing hair transplant in the active scarring alopecia might cause poor growth and subsequent loss of transplanted hairs. Physicians also require knowledge of hair vitamin supplements as an adjunctive treatment to medical and surgical treatment of alopecia. There are several studies supporting the role of vitamins and micronutrients in non-scarring alopecia. In addition, hair care products are also helpful to treat hair shaft disorders and promote the healthy look of hair. Finally, in the COVID era, there are several reports of telogen effluvium after infection and it is thought to involve more rigorously patients with androgenetic alopecia.
- Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A. The Role of Vitamins and Minerals in Hair Loss: A Review. Dermatol Ther (Heidelb). 2019 Mar;9(1):51-70. doi: 10.1007/s13555-018-0278-6. Epub 2018 Dec 13.
- Alopecia, Miteva, MI, 1st edition. Elsevier, May 15, 2018.
- Kakpovbia E, Ugonabo N, Chen A, Adhikari S, Ogbechie-Godec OA, Sicco KL, Shapiro J. Impact of Laboratory Work Up and Supplementation on Alopecia Patients: A Single-Center Retrospective Chart Review. J Drugs Dermatol. 2021 Jul 1;20(7):807-809.
- O.M. Moreno-Arrones, et al. SARS-CoV-2-induced telogen effluvium: a multicentric study. JEADV COVID-19 articles. Volume35, Issue3, March 2021, e181-e183. https://doi.org/10.1111/jdv.17045
Target Audience and Prerequisites
This webinar is taught at the physician level. It is geared toward intermediate- to advanced-level hair restoration surgeons.
As a result of participating in this activity, the learners should be able to:
- Explain the dermatopathology of common hair problems
- Identify the proper shampoo and hair care products for each patient
- Recommend the appropriate vitamin and minerals supplements for alopecia patients
- Update the knowledge of hair loss disorders after COVID-19
Internet/online, via computer or mobile device.
The official language of the webinar is English. Simultaneous interpretation is not provided for this webinar.
Disclosures of Relevant Financial Relationships of Planners, Faculty, and Others
The following individuals have no relevant financial relationships with ineligible companies to disclose:
Conradin von Albertini, MD, FISHRS – Planner
Claudia Bernárdez, MD – Faculty
Timothy P. Carman, MD, FISHRS – COI Reviewer
Victoria Ceh, MPA – Planner & Manager
Steven P. Gabel, MD, FISHRS – Planner
Rita Kaufman – Planner & Manager
Matthew Lopresti, MD – Planner
Paul J. McAndrews, MD, FISHRS – COI Reviewer
Mariya Miteva, MD – Faculty
Óscar Muñoz Moreno Arrones, MD – Faculty
Masahisa Nagai, MD – Planner
Ratchathorn Panchaprateep, MD, PhD, FISHRS – Planner & Faculty
Vladimir Ratushny, MD, PhD – Planner
Melanie Stancampiano – Planner & Manager
Antonella Tosti, MD – Faculty
Robin Unger, MD – Planner & Faculty
Mark Waldman, MD – Planner
James E Vogel, MD, FISHRS – Faculty
The following individuals have relevant financial relationships:
Robert S. Haber, MD, FISHRS – Planner
Ellis Instruments, Inc: Royalty, patent or other IP
Transdermal Cap Inc: Consultant/Advisory Board
James A. Harris, MD, FISHRS – Planner
Restoration Robotics: Consultant/Advisory Board
All of the relevant financial relationships listed for these individuals have been mitigated.
The webinar content has been made available by the ISHRS for educational purposes only. The content is not intended to represent the only, nor necessarily the best, method or procedure appropriate for the medical situations discussed, but rather is intended to present views, statements, and opinions that may be of interest to others. The views expressed herein are those of the individual authors and not necessarily those of the ISHRS. The ISHRS assumes no responsibility or liability in connection with your use or misuse of the webinar content or any materials or techniques described in the content, and it makes no warranty or representation as to the validity or sufficiency of any information provided.
Questions: Learners may contact the ISHRS Headquarters with questions about this activity at phone +1-800-444-2737 or +1-630-262-5399, or fax +1-630-262-1520, or email: [email protected]